TT
Tscan Therapeutics Inc
🇺🇸XNAS.TCRXUnited StatesHealthcare
$0.33USDup +0.01 (+3.13%)OpenDelayed5:16 PM
Price$0.33+0.01 (+3.13%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US89854M1018
- CUSIP
- 89854M101
Company
- Employees
- 138
- Headquarters
- Waltham, United States
- Website
- https://www.tscan.com
- CEO
- Dr. Gavin MacBeath Ph.D.
Market
- Shares outstanding
- 61.1M
- Market cap
- $20.15M
Highlights
- Market cap
- $19.54M
- EPS LTM
- -$0.91
- P/E LTM
- -1.07
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $7.11M+2.15%up year on year
- Net income
- -$117.71M+13.94%up year on year
- Gross margin
- 69.3%-7.64%down year on year
- Free cash flow
- -$118.44M+9.76%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.